Alexandria Real Estate Equities (ARE)

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0152711091

(NYSE:ARE Stock) Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Alexandria Real Estate Equities (ARE)

ARE Stock Overview

Market Cap in USD 20,626m
Sector Real Estate
Industry REIT - Office
GiC SubIndustry Diversified REITs
TER 0.00%
IPO / Inception 1997-05-27

ARE Stock Ratings

Fundamental 0.07
Dividend 7.31
Growth 5y -0.11
Rel. Performance vs Sector -2.58
Analysts 4.62
Fair Price Total Ret. 112.04
Fair Price DCF 19.31

ARE Dividends

Yield 12m 4.08%
Yield on Cost 5y 4.24%
Dividends CAGR 5y 4.40%
Payout Consistency 95.8%

ARE Growth Ratios

Growth 12m -18.63%
Growth Correlation 12m -12%
Growth Correlation 3m 2%
CAGR 5y 0.76%
CAGR / Mean Drawdown 0.04
Sharpe Ratio 12m -0.68
Alpha vs SP500 12m -45.74
Beta vs SP500 5y weekly 1.02
CAPM 8.06%
Average Daily Range 2m 2.65%
Regime Oscillator 68.92
Volatility GJR Garch 1y 35.03%
Price / SMA 50 -1.49%
Price / SMA 200 7.61%
Current Volume 1009.6k
Average Volume 20d 1237.6k

External Links for ARE Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of ARE stocks?
As of February 22, 2024, the stock is trading at USD 121.42 with a total of 1,009,557 shares traded.
Over the past week, the price has changed by +7.13%, over one month by -1.61%, over three months by +18.17% and over the past year by -19.47%.
Why is ARE stock down?
Check with which Index or Commodity ARE has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return ARE Return S&P 500
1 Month -1.61% 2.85%
3 Months 18.17% 10.14%
12 Months -19.47% 26.48%
What is the forecast for ARE stock price target?
According to ValueRays Forecast Model, ARE Alexandria Real Estate Equities will be worth about 121 in February 2025. The stock is currently trading at 121.42. This means that the stock has a potential downside of -0.35%.
Issuer Forecast Upside
Wallstreet Target Price 141.6 16.6%
Analysts Target Price 145.4 19.7%
ValueRay Target Price 121 -0.3%